BioCorteX
- Digital health
- Biotech or pharma, therapeutic R&D
BioCorteX is a Draper-Sofinnova VC-backed techbio company pioneering in-silico drug development to de-risk and accelerate oncology R&D when moving between geographical regions, such as from China and South Korea to the global market.
We recently announced a breakthrough in antibody-drug conjugates (ADCs) for cancer treatment, uncovering critical drug-bacteria interactions that impact therapeutic efficacy—see our joint BioCorteX-Google Cloud announcement below.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}